Apomorphine pharmacokinetic-pharmacodynamic correlations following single and repeated subcutaneous injections in patients with Parkinson's disease

被引：0
|
作者：
Bottini, PB
Shaw, A
Huang, MY
Sherry, JH
机构：
来源：
MOVEMENT DISORDERS | 2002年 / 17卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
P293
引用
收藏
页码：S101 / S101
页数：1
相关论文
共 50 条
  • [1] Pharmacokinetic-Pharmacodynamic Relationships of Apomorphine in Patients with Parkinson’s Disease
    Cees Neef
    Teus van Laar
    Clinical Pharmacokinetics, 1999, 37 : 257 - 271
  • [2] Pharmacokinetic-pharmacodynamic relationships of apomorphine in patients with Parkinson's disease
    Neef, C
    van Laar, T
    CLINICAL PHARMACOKINETICS, 1999, 37 (03) : 257 - 271
  • [3] An integrated pharmacokinetic-pharmacodynamic approach to optimization of R-apomorphine delivery in Parkinson's disease
    Danhof, M
    Van der Geest, R
    Van Laar, T
    Boddé, HE
    ADVANCED DRUG DELIVERY REVIEWS, 1998, 33 (03) : 253 - 263
  • [4] Pharmacokinetic-pharmacodynamic modeling of levodopa and metabolites in Parkinson's disease patients
    Marsot, A.
    Micallef, J.
    Azulay, J. P.
    Blin, O.
    FUNDAMENTAL & CLINICAL PHARMACOLOGY, 2017, 31 : 45 - 45
  • [5] Intermittent Subcutaneous Injections of Apomorphine in Parkinson's Disease
    Ceylan, Mustafa
    Gultekin, Murat
    Celik, Nazli Durmaz
    Samanci, Bedia
    Cakmakli, Gul Yalcin
    Yilmaz, Rezzak
    EURASIAN JOURNAL OF MEDICINE, 2022, 54 : S71 - S76
  • [6] Safety following a single subcutaneous injection of apomorphine in patients with advanced Parkinson's disease
    Gutmann, D
    MOVEMENT DISORDERS, 2004, 19 : S273 - S273
  • [7] Pharmacokinetic-pharmacodynamic relationship of levodopa with and without tolcapone in patients with Parkinson's disease
    Baas, H
    Zehrden, F
    Selzer, R
    Kohnen, R
    Loetsch, J
    Harder, S
    CLINICAL PHARMACOKINETICS, 2001, 40 (05) : 383 - 393
  • [8] Pharmacokinetic-Pharmacodynamic Relationship of Levodopa with and without Tolcapone in Patients with Parkinson’s Disease
    Horst Baas
    Frank Zehrden
    Roland Selzer
    Ralf Kohnen
    Joern Loetsch
    Sebastian Harder
    Clinical Pharmacokinetics, 2001, 40 : 383 - 393
  • [9] Pharmacokinetic-Pharmacodynamic effects of sublingual apomorphine (APL-130277) for acute rescue of OFF episodes in Parkinson's disease patients
    Dubow, Jordan
    Dzyngel, Bruce
    Bilbault, Thierry
    Giovinazzo, Anthony
    Agro, Albert
    NEUROLOGY, 2015, 85 (04) : E48 - E48
  • [10] Pharmacokinetic-Pharmacodynamic Modeling of Levodopa in Patients With Advanced Parkinson Disease
    Adamiak, Urszula
    Kaldonska, Maria
    Klodowska-Duda, Gabriela
    Wyska, Elzbieta
    Safranow, Krzysztof
    Bialecka, Monika
    Gawronska-Szklarz, Barbara
    CLINICAL NEUROPHARMACOLOGY, 2010, 33 (03) : 135 - 141
12345